Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Dr Vincent Simpson says the reusable pens reduce plastic waste and could save the NHS money.

and the company said last year it was shifting away from its century-long focus on making insulin to treat diabetes to making weight-loss drugs to combat obesity as a precursor to type 2 diabetes.

As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

Digital health tools, artificial intelligence (AI), and wearable devices are leading the way in transforming the landscape ...